María José Munoz Alonso

Title: Innovations by María José Munoz Alonso in Antibody Drug Conjugates

Introduction

María José Munoz Alonso is a notable inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody drug conjugates. Her work focuses on innovative solutions for cancer treatment, showcasing her expertise and dedication to advancing medical science.

Latest Patents

María José holds a patent for antibody drug conjugates, specifically a drug conjugate of the formula [D-(X)b-(AA)w-(L)-]n-Ab. This invention includes a drug moiety that is designed to target cancer cells effectively. The conjugates are characterized by various components, including an extending group, amino acid units, and linker groups, which enhance their therapeutic potential. This patent represents a significant advancement in targeted cancer therapies.

Career Highlights

María José is currently associated with Pharma Mar, S.A., a company renowned for its innovative approaches in oncology. Her role at Pharma Mar has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry. With her expertise, she has played a crucial role in advancing the company's mission to provide effective cancer treatments.

Collaborations

One of her notable collaborators is Cármen Cuevas Marchante. Together, they have worked on various projects that aim to enhance the efficacy of cancer therapies through innovative drug design.

Conclusion

María José Munoz Alonso's contributions to the field of antibody drug conjugates exemplify her commitment to improving cancer treatment. Her innovative work continues to inspire advancements in medical research and pharmaceutical development.